|
1) Lindner A, Charra B, Sherrard DJ, et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974; 290: 697-701
|
|
|
|
2) Joki N, Hase H, Nakamura R, et al. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant. 1997; 12: 718-23
|
|
|
|
|
3) Yasuda K, Kasuga H, Aoyama T, et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol. 2006; 17: 2322-32
|
|
|
|
|
|
4) Gowdak LH, de Paula Fj, Cesar LA, et al. Screening for significant coronary artery disease in high-risk renal transplant candidates. Coron Artery Dis. 2007; 18: 553-8
|
|
|
|
|
|
5) Soubassi LP. Papadakis ED, Theodoropoulos IK, et al. Incidence and risk factors of coronary artery disease in patients on chronic hemodialysis. Int J Artif Organs. 2007; 30: 253-7
|
|
|
|
|
|
6) Nishimura M, Hashimoto T, Kobayashi H, et al. Myocardial scintigraphy using fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int. 2004; 66: 811-9
|
|
|
|
|
|
7) Hase H, Joki N, Ishikawa H, et al. Independent risk factors for progression of coronary atherosclerosis in hemodialysis. Ther Apher Dial. 2006; 10: 321-7
|
|
|
|
|
8) Ohtake T, Kobayashi S, Moriya H, et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. Am J Soc Nephrol. 2005; 16: 1141-8
|
|
|
|
|
|
9) Hase H, Thunoda T, Tanaka Y, et al. Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom. Kidney Int. 2006; 70: 1142-8
|
|
|
|
|
|
10) Tanaka Y, Joki N, Hase H. History of coronary events during the predialysis phase of chronic kidney disease is a strong risk factor for major adverse cardiac events in patients initiating haemodialysis. Nephrol Dial Transplant. 2007; 22: 2917-23
|
|
|
|
|
|
11) Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-305
|
|
|
|
|
|
12) Nishimura M, Murase M, Hashimoto T, et al. Insulin resistance and impared myocardial fatty acid metabolism in dialysis patients with normal coronary arteries. Kidney Int. 2006; 69: 553-9
|
|
|
|
|
|
13) Nishimura M, Tsukamoto K, Hasebe N, et al. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol. 2008; 51: 139-45
|
|
|
|
|
|
14) McIntyre CW, Burton JO, Selby NM, et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global segmental myocardial blood flow. Clin J Am Soc Nephrol. 2008; 3: 19-26
|
|
|
|
|
|
15) http://www.usrds.org/2005/pres/06U_asn_05_CV_event_rates.pdf
|
|
|
|
|
|
16) Herzog CA, Littrell K, Arko C, et al. Clinical characteristics of dialysis patients with acute myocardial infarction in the United States. Circulation. 2007; 116: 1465-72
|
|
|
|
|
|
17) Charytan D, Mauri L, Agarwal A, et al. The use of invasive procedures after acute myocardial infarction in long-term dialysis patients. Am Heart J. 2006; 152: 558-64
|
|
|
|
|
|
18) http://www.usrds.org/adr/htm
|
|
|
|
|
|
19) Reddan DN, Szczech LA, Tuttle RH, et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol. 2003; 14: 2373-80
|
|
|
|
|
|
20) Hase H, Nakamura M, Joki N, et al. Independent predictors of restenosis after percutaneous coronary revascularization in haemidialysis patients. Neprol Dial Transplant. 2001; 16: 2372-7
|
|
|
|
|
|
21) Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002; 106: 2207-11
|
|
|
|
|
|
22) Halkin A, Selzer F, Marroquin O, et al. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol. 2006; 18: 577-83
|
|
|
|
|
|
23) Boden W, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356: 1503-16
|
|
|
|
|